African and Caribbean nations ravaged by the HIV epidemic will be able to obtain low-cost generic versions of 2 key antiretroviral drugs under a deal brokered by former President Bill Clinton's AIDS Foundation.
Under the arrangement, poor countriesincluding Swaziland, Lesotho, Seychelles, Mauritius, and Madagascarwill get access to generic efavirenz and abacavir at prices that have been estimated at $240 per patient per year.
Aspen Pharmacare and Indian generic drug manufacturers Ranbaxy, Cipla, and Strides Acrolabs will supply efavirenz. Cipla will also supply abacavir.
5 Studies That Shaped HIV Treatment That Every Pharmacist Should Know
Over the years, a number of landmark clinical studies in the field of virology have been published, shaping how we treat many infectious diseases today.
News from the year's biggest meetings
Clinical features with downloadable PDFs